Clinical significance of treatment-induced lipid abnormalities and lipodystrophy.
Smith
D
D
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001823:Body Composition; D002318:Cardiovascular Diseases / Q000209:etiology; D015331:Cohort Studies; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000150:complications; D008055:Lipids / Q000097:blood*; D008060:Lipodystrophy / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
D017320:HIV Protease Inhibitors; D008055:Lipids; D018894:Reverse Transcriptase Inhibitors